You are here

J&J drug unit to leverage Singapore's biotech hub

'Very lively biotech hub' spurs pharmaceutical arm's external collaborations

BT_20181029_ABJANS17_3601300.jpg
Group chairman Ong Ai Hua says Janssen Asia Pacific's focus in Singapore is more on innovation than manufacturing.

Singapore

JOHNSON & Johnson's (J&J) regional pharmaceutical head believes that Singapore offers innovation, research and development tie-up opportunities, even as wider insurance coverage in the Asia-Pacific is expected to fuel growth for drugmakers.

Ong Ai Hua, the group...

sentifi.com

Market voices on: